结果重组人生长激素显著增加骨质疏松大鼠的骨密度，对改善松质骨骨量及骨结构参数都有显著作用。
Results Recombinant human growth hormone significantly increased bone mineral density and improved the cancellous bone volume and trabecular bone architectures.
而骨密度在治疗后一年内有显著增加，而后趋于平缓。
The alveolar bone density increased significantly and approached to a flat after one-year's treatment.
减少破骨细胞数（P<0.01）且显著增加去卵巢大鼠股骨骨密度（P<0.05）。
Moreover, Er-xian decoction obviously reduced osteoclast number(P<0.01)and enhanced bone density of femur metaphysis in ovariectomized rats(P<0.05).
应用推荐